HKII is overexpressed in cancer cells, while its lowexpressed in normal cells, as HKII is specifically required by cancer cells, therefore inhibiting HKII can interfere with cancer progression, which provides a window to target HKII without harming normal cell.50, 51. The gene discussed is HK2; the disease is cancer.